Agency Forms Undergoing Paperwork Reduction Act Review, 57437-57438 [2019-23367]
Download as PDF
<![CDATA[
57437
Federal Register / Vol. 84, No. 207 / Friday, October 25, 2019 / Notices
clearance will be consistent with CDC/
OTI goals for promoting scientific
innovation, customer engagement, and
entrepreneurship in public health.
OMB approval is requested for three
years. Individual projects must be
approved by CDC’s OTI before they are
submitted to OMB for final review and
approval. CDC estimates the estimated
annual burden hours to be 250.
Participation is voluntary, and there are
no costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Avg. burden
per response
(in hrs.)
Total burden
(in hrs.)
Type of respondents
Form name
External Partners, Stakeholders, or
Customers.
Interview Guides, Questionnaires,
and Surveys.
500
1
30/60
250
Total ...........................................
...........................................................
........................
........................
........................
250
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–23366 Filed 10–24–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–1128]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘State
Unintentional Drug Overdose Reporting
System (SUDORS)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on April 2,
2019 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
18:04 Oct 24, 2019
Jkt 250001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
State Unintentional Drug Overdose
Reporting System (SUDORS) (OMB
Control No. 0920–1128, Exp. 10/31/
2020)—Revision—National Center for
Injury Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
There has been a rapid increase in
opioid overdose deaths since 2013. In
the United States, more people are now
dying of drug overdose than automobile
crashes, although opioids—both opioid
pain relievers (OPRs) and illicit forms
such as heroin—are also a major factor
in overdose-related automobile crashes.
On October 26, 2017, the U.S.
Department of Health and Human
Services (HHS) declared the opioid
overdose epidemic to be a national
public health emergency.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
CDC established the State
Unintentional Drug Overdose Reporting
System (SUDORS) in order to detect
new trends in fatal unintentional drug
overdoses, support targeting of drug
overdose prevention efforts, and assess
the progress of the HHS initiative to
reduce opioid misuse and overdoses.
Respondents are state- or jurisdictionlevel health departments. The SUDORS
surveillance system generates detailed,
timely public health information on
unintentional, fatal opioid-related drug
overdoses and has been used to inform
prevention and response efforts at the
national, state, and local levels.
SUDORS consolidates and supplements
information available to health
departments, including vital statistics
and records created by medical
examiners and coroners (ME/C).
SUDORS is built on a web-based
software platform and a collaborative
surveillance and data integration model
developed by CDC and health
departments to improve understanding
of homicide, suicide, undetermined
deaths, and unintentional firearm
deaths (National Violent Death
Reporting System (NVDRS), OMB No.
0920–0607, exp. 11/30/2020).
Through SUDORS, CDC currently
collects information that is not provided
on death certificates, such as whether
the drug(s) causing the overdoses were
injected or taken orally; a toxicology
report on the decedent, if available; and
risk factors for fatal drug overdoses
including previous drug overdoses,
decedent’s mental health, and whether
the decedent recently exited a treatment
program. Without this information,
efforts to prevent drug overdose deaths
are often based on limited information
available on the death certificate and
anecdotal evidence.
During the next three years, CDC will
update the web-based SUDORS
interface to improve system
performance, functionality, and
accessibility. CDC and health
E:\FR\FM\25OCN1.SGM
25OCN1
57438
Federal Register / Vol. 84, No. 207 / Friday, October 25, 2019 / Notices
departments will also expand the
SUDORS case definition beyond the
current focus on opioid-related overdose
deaths to include all individuals who
died of an unintentional or
undetermined intent drug-related
overdose. The expanded focus will
allow CDC and health departments to
begin characterizing overdose deaths
attributable to emerging illicit drug
threats (e.g., non-opioid synthetic
drugs), deaths attributable to opioid couse with other classes of drugs (e.g.,
gabapentin or benzodiazapine), and the
extent to which certain types of
prescription drugs (both opioid and
non-opioid) are involved in fatal
overdoses.
Participating states and jurisdictions
will continue to report SUDORS
information to CDC through a module in
the NVDRS web-based platform. Stateand jurisdiction-level public health
departments will be funded to abstract
standardized data elements from ME/C
reports as well as death certificates.
Beginning in 2020, cooperative
agreement goals include reducing the
time lag for reporting from eight months
to no more than six months. Information
can be entered into the SUDORS system
at any time, but reports on overdose
deaths that occur between January 1 and
June 30 will be entered into the
SUDORS by December of the same
calendar year. Data entry for overdose
deaths that occur between July 1 and
December 31 will be complete by June
of the next calendar year. The
accelerated reporting schedule is
needed to support timely identification
of the causes of overdose deaths, and
effective public health intervention.
This Revision request does not entail
a change in the estimated burden per
response, which is based on the time
needed for a health department to
retrieve and refile vital statistics
records, ME/C records, etc. The
estimated burden per response does not
include the time needed to abstract
SUDORS data variables from those
sources, since this activity is funded by
the SUDORS cooperative agreement.
Total estimated annualized burden will
increase due to the inclusion of
additional types of overdose-related
deaths. Also, increased Congressional
appropriation in 2019 to expand
SUDORS nationwide as a component of
CDC’s Overdose Data to Action (OD2A)
Notice of Funding Opportunity (NOFO)
(CDC–RFA–CE19–1904, posted
February 1, 2019) requires expanding
the number of participating jurisdictions
from 50 to 52. OMB approval is
requested for three years. The total
estimated annualized burden hours are
32,838.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Public Agencies ..............................................
Retrieving and refiling records .......................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–23367 Filed 10–24–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Council for the
Elimination of Tuberculosis Meeting
(ACET). This meeting is open to the
public, limited to 80 room seats and 100
ports for audio phone lines. Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt is
SUMMARY:
VerDate Sep<11>2014
18:04 Oct 24, 2019
Jkt 250001
Monday, December 9, 2019. Persons
who desire to make an oral statement,
may request it at the time of the public
comment period on December 11, 2019
at 11:40 a.m., EST.
DATES: The meeting will be held on
December 10, 2019, 8:30 a.m. to 4:30
p.m., EST and December 11, 2018, 8:30
a.m. to 12:00 p.m., EST.
ADDRESSES: CDC, 8 Corporate
Boulevard, Building 8, Conference
Rooms 1–A/B/C, Atlanta, Georgia
30329–4027 and Web conference: 1–
877–927–1433 and participant
passcode: 12016435 and https://
adobeconnect.cdc.gov/r5p8l2tytpq/.
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road NE, Mailstop: E–07,
Atlanta, Georgia 30329–4027, telephone
(404) 639–8317; zkr7@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
PO 00000
Frm 00057
Fmt 4703
Sfmt 9990
Total
number of
responses per
respondent
52
1,263
Average
burden per
response
(in hours)
30/60
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters To Be Considered: The agenda
will include discussions on (1) Use of
Project ECHO in supporting tuberculosis
(TB) activities; (2) Update on CDC
Centers of Excellence for TB Training,
Education and Medical Consultation; (3)
Update on Latent Tuberculosis Infection
(LTBI) communications campaign; (4)
TB Host Directed Therapy; and (5)
Updates from ACET workgroups.
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–23237 Filed 10–24–19; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Pages 57437-57438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23367]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-1128]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``State Unintentional Drug Overdose Reporting
System (SUDORS)'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
April 2, 2019 to obtain comments from the public and affected agencies.
CDC did not receive comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
State Unintentional Drug Overdose Reporting System (SUDORS) (OMB
Control No. 0920-1128, Exp. 10/31/2020)--Revision--National Center for
Injury Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
There has been a rapid increase in opioid overdose deaths since
2013. In the United States, more people are now dying of drug overdose
than automobile crashes, although opioids--both opioid pain relievers
(OPRs) and illicit forms such as heroin--are also a major factor in
overdose-related automobile crashes. On October 26, 2017, the U.S.
Department of Health and Human Services (HHS) declared the opioid
overdose epidemic to be a national public health emergency.
CDC established the State Unintentional Drug Overdose Reporting
System (SUDORS) in order to detect new trends in fatal unintentional
drug overdoses, support targeting of drug overdose prevention efforts,
and assess the progress of the HHS initiative to reduce opioid misuse
and overdoses. Respondents are state- or jurisdiction-level health
departments. The SUDORS surveillance system generates detailed, timely
public health information on unintentional, fatal opioid-related drug
overdoses and has been used to inform prevention and response efforts
at the national, state, and local levels. SUDORS consolidates and
supplements information available to health departments, including
vital statistics and records created by medical examiners and coroners
(ME/C). SUDORS is built on a web-based software platform and a
collaborative surveillance and data integration model developed by CDC
and health departments to improve understanding of homicide, suicide,
undetermined deaths, and unintentional firearm deaths (National Violent
Death Reporting System (NVDRS), OMB No. 0920-0607, exp. 11/30/2020).
Through SUDORS, CDC currently collects information that is not
provided on death certificates, such as whether the drug(s) causing the
overdoses were injected or taken orally; a toxicology report on the
decedent, if available; and risk factors for fatal drug overdoses
including previous drug overdoses, decedent's mental health, and
whether the decedent recently exited a treatment program. Without this
information, efforts to prevent drug overdose deaths are often based on
limited information available on the death certificate and anecdotal
evidence.
During the next three years, CDC will update the web-based SUDORS
interface to improve system performance, functionality, and
accessibility. CDC and health
[[Page 57438]]
departments will also expand the SUDORS case definition beyond the
current focus on opioid-related overdose deaths to include all
individuals who died of an unintentional or undetermined intent drug-
related overdose. The expanded focus will allow CDC and health
departments to begin characterizing overdose deaths attributable to
emerging illicit drug threats (e.g., non-opioid synthetic drugs),
deaths attributable to opioid co-use with other classes of drugs (e.g.,
gabapentin or benzodiazapine), and the extent to which certain types of
prescription drugs (both opioid and non-opioid) are involved in fatal
overdoses.
Participating states and jurisdictions will continue to report
SUDORS information to CDC through a module in the NVDRS web-based
platform. State- and jurisdiction-level public health departments will
be funded to abstract standardized data elements from ME/C reports as
well as death certificates. Beginning in 2020, cooperative agreement
goals include reducing the time lag for reporting from eight months to
no more than six months. Information can be entered into the SUDORS
system at any time, but reports on overdose deaths that occur between
January 1 and June 30 will be entered into the SUDORS by December of
the same calendar year. Data entry for overdose deaths that occur
between July 1 and December 31 will be complete by June of the next
calendar year. The accelerated reporting schedule is needed to support
timely identification of the causes of overdose deaths, and effective
public health intervention.
This Revision request does not entail a change in the estimated
burden per response, which is based on the time needed for a health
department to retrieve and refile vital statistics records, ME/C
records, etc. The estimated burden per response does not include the
time needed to abstract SUDORS data variables from those sources, since
this activity is funded by the SUDORS cooperative agreement. Total
estimated annualized burden will increase due to the inclusion of
additional types of overdose-related deaths. Also, increased
Congressional appropriation in 2019 to expand SUDORS nationwide as a
component of CDC's Overdose Data to Action (OD2A) Notice of Funding
Opportunity (NOFO) (CDC-RFA-CE19-1904, posted February 1, 2019)
requires expanding the number of participating jurisdictions from 50 to
52. OMB approval is requested for three years. The total estimated
annualized burden hours are 32,838.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Total number Average burden
Type of respondent Form name Number of of responses per response
respondents per respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Public Agencies.................... Retrieving and refiling 52 1,263 30/60
records.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-23367 Filed 10-24-19; 8:45 am]
BILLING CODE 4163-19-P
